Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Research fostered at RDM has increased the accuracy of echocardiogram interpretations, pinpointing many more people at risk of heart disease.

As part of its artificial intelligence showcase, Oxford University interviews Professor Paul Leeson, who heads the Cardiovascular Clinical Research Facility at RDM.

Professor Leeson is one of the founders of Ultromics, which aims to use artificial intelligence to improve the accuracy of echocardiograms interpretation – echocardiograms are the most widely used imaging test for people with heart disease, but it needs an expert to interpret the images and reach a diagnosis.

When the expert is good, then the test can be very accurate. But because levels of experience vary, this can be difficult to control. - Paul Leeson

But Professor Leeson’s team were able to use machine learning to get accurate clinical interpretations which outstripped human doctors, by combining machine learning and clinical know-how to identify associations between features in the echocardiography images and patient outcomes.

Find out more about how this technique could save lives by identifying more people at risk of heart disease.

Similar stories

The effect of nuclear pH on cardiac gene expression

Research led by Dr Alzbeta Hulikova and Professor Pawel Swietach has, for the first time, described the potential regulation of nuclear acid-base chemistry in neonatal and adult cardiomyocytes, and explained its relevance in the context of heart physiology and pathology.

Study indicates reasons for decline in death rates from heart attacks

A new study involving Oxford Population Health researchers finds that both prevention and improved treatments have helped reduce deaths from heart attacks - but the relative importance of each varies by country, age and sex.

Review highlights impact of Long COVID on cardiovascular system

The wide-ranging effects of Long COVID and the associated issues for healthcare providers have been revealed in a new review of the major studies into the condition, which specifically highlights the impact of Long COVID on the cardiovascular system.

Commercial development of therapeutic anti-inflammatory peptide begins

An Oxford BHF CRE “Pump Priming” award to Professor Shoumo Bhattacharya and his research group led to a great return on investment with this exclusive licensing agreement for their innovative research.

London Marathon to fund De Val and Vieira Lab research as two of eight handpicked BHF projects

Two projects aimed at tackling heart failure led by Associate Professor Sarah De Val and Dr Joaquim Vieira are to be funded by the 2022 TCS London Marathon with the British Heart Foundation as its Charity of the Year. The BHF’s runners, who are raising £3 million in funding, will include De Val Lab postdoctoral researcher Dr Alice Neal.

Dr Qiang Zhang wins Society for Cardiovascular Magnetic Resonance Early Career Award 2022

Many congratulations to Dr Qiang Zhang, Oxford BHF CRE Transition Fellow, who has won a prestigious award for his work in developing a groundbreaking technology for detecting scar in the myocardium